FDA approves 2006 strain of flu vaccine

Aug 03, 2006

The U.S. Food and Drug Administration has approved the manufacture of this year's seasonal influenza vaccine.

The vaccine is designed to fight new virus strains scientists believe are likely to cause flu in the Northern Hemisphere during 2006-07.

Each year influenza vaccine manufacturers submit information and samples to the FDA of the virus strains to be produced for the upcoming seasonal influenza season. This season's FDA-approved formulation is identical to that recommended by the World Health Organization. The formulation includes one strain that was used in last year's vaccine and two new strains.

Seasonal flu vaccines do not protect against avian influenza, which is caused by different viral strains.

The U.S. Centers for Disease Control and Prevention say up to 20 percent of the U.S. population is stricken by influenza annually, with about 200,000 people requiring hospitalization and approximately 36,000 people dying from the disease.

At high risk for serious flu complications are elderly people, children and people with certain chronic medical conditions.

Copyright 2006 by United Press International

Explore further: New clinical trial launched for advance lung cancer

add to favorites email to friend print save as pdf

Related Stories

Protecting competition horses from the flu

Nov 05, 2013

A deep hacking cough, a runny nose and fever—just like humans, horses can suffer badly when struck down by the flu. Although equine influenza is rarely fatal, it is highly contagious and can seriously disrupt ...

Researchers use microRNA to trap mutant viruses in the lab

Aug 12, 2013

(Phys.org) —It's a scenario straight out of a sci-fi horror flick. Scientists take a deadly virus that people can only catch from birds and genetically engineer it so we can give it to each other. Unfortunately, ...

Recommended for you

New clinical trial launched for advance lung cancer

51 minutes ago

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

User comments : 0

More news stories

New clinical trial launched for advance lung cancer

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

More vets turn to prosthetics to help legless pets

A 9-month-old boxer pup named Duncan barreled down a beach in Oregon, running full tilt on soft sand into YouTube history and showing more than 4 million viewers that he can revel in a good romp despite lacking ...